PDX Pharmaceuticals filed international patent applications (PCT) on cancer immunotherapeutics and a provisional application on COVID-19 vaccine

PDX Pharmaceuticals is proud to report that we have filed two international patent applications (PCT) on cancer immunotherapeutics and a provisional application on COVID-19 vaccine today. Protection of intellectual properties (IPs) is our top priority and we work with one of the best IP law firms, Clark+Elbing, Boston, for patent application preparation and prosecution.

– Immunogenic Constructs, Compositions, and Methods for Inducing Immune Response, 63/051,351

– Immunotherapeutic Constructs and Methods of Their Use, PCT/US20/41844

– Therapeutic Constructs for Co-Delivery of Mitotic Kinase Inhibitor and Immune Checkpoint Inhibitor, PCT/US20/41852